Menu Search
Equities

Mega Lifesciences PCL

  • Add to watchlist
  • Add to portfolio
  • Add an alert
MEGA-F:SET

Mega Lifesciences PCL

Actions
  • Price (THB)--
  • Today's Change--
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
Abrdn Asia Ltd.as of 30 Jan 202617.73m0.00%
The Vanguard Group, Inc.as of 04 Feb 202613.08m0.00%
FIL Investment Management (Singapore) Ltd.as of 31 Dec 202512.06m0.00%
Dimensional Fund Advisors LPas of 30 Nov 20253.15m0.00%
TT International (Hong Kong) Ltd.as of 30 Nov 2025893.20k0.00%
Parametric Portfolio Associates LLCas of 31 Dec 2025346.00k0.00%
Probus Pleion Middle East Ltd.as of 30 Jun 2025340.00k0.00%
Keyridge Asset Management Ltd.as of 05 Feb 2026325.27k0.00%
Vanguard Fiduciary Trust Co.as of 30 Nov 2025311.73k0.00%
TIAA-CREF Investment Management LLCas of 31 Dec 2025287.90k0.00%
More ▼
Data from 30 Jun 2025 - 12 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.